• Sector: Healthcare
  • Geography: France, United States
  • Stage: Late
  • Investment Year: 2020
  • Website Link


Founded in 2001 and based in Strasbourg, France, Polyplus is a leading global supplier of transfection reagents, which are critical inputs used in the manufacturing of cell and gene therapies. Polyplus’ reagents are embedded in the majority of clinical-stage and commercially approved drugs in the rapidly growing gene therapy market.